282 related articles for article (PubMed ID: 22946432)
1. Mesenchymal stem cells in drug/gene delivery: implications for cell therapy.
Greco SJ; Rameshwar P
Ther Deliv; 2012 Aug; 3(8):997-1004. PubMed ID: 22946432
[TBL] [Abstract][Full Text] [Related]
2. Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases.
Reiser J; Zhang XY; Hemenway CS; Mondal D; Pradhan L; La Russa VF
Expert Opin Biol Ther; 2005 Dec; 5(12):1571-84. PubMed ID: 16318421
[TBL] [Abstract][Full Text] [Related]
3. The future of mesenchymal stem cell-based therapeutic approaches for cancer - From cells to ghosts.
Mohr A; Zwacka R
Cancer Lett; 2018 Feb; 414():239-249. PubMed ID: 29175461
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells as the game-changing tools in the treatment of various organs disorders: Mirage or reality?
Marofi F; Vahedi G; Hasanzadeh A; Salarinasab S; Arzhanga P; Khademi B; Farshdousti Hagh M
J Cell Physiol; 2019 Feb; 234(2):1268-1288. PubMed ID: 30191962
[TBL] [Abstract][Full Text] [Related]
5. The Importance of HLA Assessment in "Off-the-Shelf" Allogeneic Mesenchymal Stem Cells Based-Therapies.
Kot M; Baj-Krzyworzeka M; Szatanek R; Musiał-Wysocka A; Suda-Szczurek M; Majka M
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766164
[TBL] [Abstract][Full Text] [Related]
6. Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas.
Choi SA; Lee JY; Wang KC; Phi JH; Song SH; Song J; Kim SK
Eur J Cancer; 2012 Jan; 48(1):129-37. PubMed ID: 21664124
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells and their potential as cardiac therapeutics.
Pittenger MF; Martin BJ
Circ Res; 2004 Jul; 95(1):9-20. PubMed ID: 15242981
[TBL] [Abstract][Full Text] [Related]
8. Fetal mesenchymal stem cells in cancer therapy.
Bitsika V; Vlahou A; Roubelakis MG
Curr Stem Cell Res Ther; 2013 Mar; 8(2):133-43. PubMed ID: 23176305
[TBL] [Abstract][Full Text] [Related]
9. Methodology, biology and clinical applications of human mesenchymal stem cells.
Camassola M; de Macedo Braga LM; Chagastelles PC; Nardi NB
Methods Mol Biol; 2012; 879():491-504. PubMed ID: 22610579
[TBL] [Abstract][Full Text] [Related]
10. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Potential of Mesenchymal Stem Cells in Immune-Mediated Diseases.
Eljarrah A; Gergues M; Pobiarzyn PW; Sandiford OA; Rameshwar P
Adv Exp Med Biol; 2019; 1201():93-108. PubMed ID: 31898783
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells for the treatment of neurodegenerative and psychiatric disorders.
Colpo GD; Ascoli BM; Wollenhaupt-Aguiar B; Pfaffenseller B; Silva EG; Cirne-Lima EO; Quevedo J; Kapczinski F; Rosa AR
An Acad Bras Cienc; 2015 Aug; 87(2 Suppl):1435-49. PubMed ID: 26247151
[TBL] [Abstract][Full Text] [Related]
13. Improved therapeutic potential of MSCs by genetic modification.
Wei W; Huang Y; Li D; Gou HF; Wang W
Gene Ther; 2018 Dec; 25(8):538-547. PubMed ID: 30254305
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
Yi T; Song SU
Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?
Rozier P; Maria A; Goulabchand R; Jorgensen C; Guilpain P; Noël D
Front Immunol; 2018; 9():2938. PubMed ID: 30619298
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells: new approaches for the treatment of neurological diseases.
Momin EN; Mohyeldin A; Zaidi HA; Vela G; Quiñones-Hinojosa A
Curr Stem Cell Res Ther; 2010 Dec; 5(4):326-44. PubMed ID: 20528757
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
[TBL] [Abstract][Full Text] [Related]
18. Strategies for improved targeting of therapeutic cells: implications for tissue repair.
Ansboro S; Greiser U; Barry F; Murphy M
Eur Cell Mater; 2012 Apr; 23():310-8; discussion 318-9. PubMed ID: 22522285
[TBL] [Abstract][Full Text] [Related]
19. Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue.
Xu L; Liu Y; Sun Y; Wang B; Xiong Y; Lin W; Wei Q; Wang H; He W; Wang B; Li G
Stem Cell Res Ther; 2017 Dec; 8(1):275. PubMed ID: 29208029
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool.
García-Castro J; Trigueros C; Madrenas J; Pérez-Simón JA; Rodriguez R; Menendez P
J Cell Mol Med; 2008 Dec; 12(6B):2552-65. PubMed ID: 19210755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
